MedTrace Logo

Adductor Endurance Test: Validity and Reliability

NCT07297537 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-12-30

No results posted yet for this study

Summary

Groin and hip injuries are common in team sports-especially soccer, rugby, and ice hockey-and frequently affect male and young athletes. About 14% of all sports injuries involve the groin and hip region, with most related to the adductor muscles. These injuries often increase during congested match periods and may result in athletes missing 1 to 6.9 weeks of training or competition, extending up to 14 weeks when surgery is required. Weakness in the adductor muscles is a key risk factor for groin injuries, and current assessments primarily measure maximal strength using tools such as squeeze tests, sphygmomanometers, or dynamometers. However, muscle endurance-critical because many injuries occur under fatigue-has not been adequately studied, and no validated endurance tests for the hip adductors exist. This study aims to evaluate the validity and reliability of a newly developed hip adductor endurance test for monitoring endurance strength in professional soccer players.

Conditions

  • Groin Injury
  • Hip Injuries
  • Athletic Injuries

Interventions

OTHER

Hip Adductor Endurance and Strength Testing

Participants will perform the Hip Adductor Endurance Test to assess adductor muscle endurance, followed by isometric maximum force assessment using the fixed dynamometer (GroinBar) . Tests are conducted in randomized order before routine training sessions, after a 5-minute light aerobic warm-up and dynamic stretching

Sponsors & Collaborators

  • Izmir Democracy University

    lead OTHER

Principal Investigators

  • Betül Taspinar, Prof.Dr. · Izmir Democracy University

  • Ayşe Sezgi Kızılırmak Karataş, Pt.PhD · Izmir Democracy University

  • Mesut Buğday, Pt. · Göztepe Sports Club

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-15
Primary Completion
2026-09-15
Completion
2026-10-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07297537 on ClinicalTrials.gov